Abstract-Effects
of orally administered TA-0910, a new thyrotropin-releasing hormone (TRH) analog, on the central nervous system (CNS) were investigated and compared with those of TRH. TA-0910 shortened the duration of pentobarbitalinduced sleep and antagonized reserpine-induced hypothermia at 0.3 mg/kg or more in mice. TA-0910 enhanced the spontaneous motor activity at the higher dose of 30 mg/kg in mice. The drug also activated acute spontaneous EEGs in rabbits at 1 mg/kg. TRH produced these effects at about 100 times higher doses than TA-0910. In antagonizing pentobarbital-induced sleep, the dose ratios of i.v. versus p.o. of TA-0910 and TRH were about 1/10 and 1/100, respectively.
The duration of the antagonistic action of TA-0910 on pentobarbital-induced sleep in mice was about 8 times longer than that of TRH when administered orally as well as intraveneously. These potent and long-acting TA-0910 effects on the CNS are discussed in connec tion with its biotransformation.
Thyrotropin releasing hormone (TRH), a tripeptide hormone, is biosynthesized mainly in the hypothalamus and stimulates the re lease of thyroid-stimulating-hormone (TSH) (1) and prolactin (PRL) (2) from the anterior lobe of the hypophysis. TRH widely exists in the brain and spinal cord (3, 4) , and is known, apart from its hormonal action, to have CNS activating actions such as shortening the duration of anesthesia (5, 6), enhancement of motor activity (7, 8) and EEG activation (9, 10). Thus, recently, much attention has been given to TRH, biologically and pharmacologi cally, and its physiological role and mech anism of action.
Silk (11) showed that the intestinal ab sorption rates of free amino acids were lower than those of di or tripeptides containing corresponding amino acids. Furthermore, di or tripeptides were indicated to be transported with a carrier in the intestinal mucous mem brane (12). Thus, it is considered that the intestinal absorption of peptides is better than that of free amino acids and, at least, tripep tides are absorbed as unchanged forms, but not as free amino acids after hydrolysis. In fact, it has been demonstrated that orally ad ministered TRH is absorbed in the upper part of the small intestine as an unchanged form (13). However, CNS activity in response to TRH is greatly reduced when it administered orally as compared with parenteral adminis tration. Furthermore, TRH has undesirable properties as a centrally acting drug; it is rapidly inactivated by TRH catabolic enzymes, such as thyroliberinase and TRH deamidase (14, 15), poorly transported in the brain (16), and exhibits endocrine action at much lower doses than those producing CNS actions (17).
To improve these undesirable properties of TRH, we synthesized a series of TRH analogs by chemical modifications of the pyroglutamyl residue of TRH. Among them, TA-0910, 1 methyl-(S) 4,5-dihydroorotyl L histidyl -L prolineamide, was found to have 30-100 times more potent CNS activity in mice and rats and 50 times weaker TSH-releasing ac tivity in rats than TRH (M. Suzuki et al., unpublished data) . In the present study, CNS activity of orally administered TA-0910 was investigated and compared with that of TRH.
Materials and Methods

Materials
The experiments were performed on male Std:ddY mice (28-32 g) and female and male KBL:JW rabbits (2.7-3.5 kg). The animals were housed as follows: mice, 25 each in a plastic cage (42 x 26 x 1 5 cm), rabbits, each in an individual aluminium cage (33x35x47 cm). All the animals were kept in the animal room maintained at 23±1 °C with 55±5% humidity and illuminated for 12 hr (6:30 a.m. 6:30 p.m.). The mice and rabbits were al lowed free access to pellet diets, CRF-1 and RC4 (both Oriental Yeast, Co., Ltd.), respec tively, as well as to tap water.
TA Both TA-0910 and TRH were dissolved in distilled water for oral administration and in 0.9% physiological saline (Ohtsuka) for in travenous or intraperitoneal administration. The volume administered was 10 ml/kg in mice and 1 ml/kg in rabbits for each dosing route.
Methods
Effect on pentobarbital-induced sleep: Mice received pentobarbital (55 mg/20 ml/ kg, i.p.) just after oral administration or 10 min before i.v. administration of the test drugs.
The duration of sleep was measured as the time from the onset of loss of the righting reflex by pentobarbital treatment until reap pearance of the righting reflex. For the mea surement of duration of action of the test drugs, the doses required to shorten the dura tion of sleep by about 40% in the above ex periment were given orally or intravenously at various times prior to the treatment with pentobarbital.
The sleeping time was mea sured as described above.
Effect on locomotor activity: Locomotor activity was measured with an Ambulometer (AMB-10, Ohara Medical Industry).
Mice were placed individually in an open polyethyl ene bucket type cage (height: 18 cm, inside base diameter: 25.5 cm, capacity: 7.3 I). The test drugs were orally administered after the mice were acclimatized to the surroundings for 30 min. The locomotor activity (locomo tion) was measured at 30-min intervals for 180 min after administration of the test drugs.
Effect on reserpine-induced hypothermia: Mice with rectal temperatures of 30°C or lower about 18 hr after subcutaneous ad ministration of reserpine (3 mg/kg) were used. Rectal temperature was measured 30 min before and 30, 60, 120, 180 and 300 min after oral administration of the test drugs and 30 min before and 15, 30, 60, 120 and 180 min after intraperitoneal administration. The measurement was performed with a thermistor (MGA-III, Nihon Kohden) at 23±1 °C and 55±5% humidity. The antagonistic effect of the test drugs on reserpine-induced hypother mia was evaluated on the basis of the area under the temperature/time curve after dosing. Effect on EEG: Sixteen rabbits were in tubated with tracheal tubes under ether anes thesia and restrained in a stereotaxic instru ment (Takahashi Co., Ltd.). Cortical EEG's were recorded on an electroencephalograph (EEG-4109, Nihon Kohden) through the monopolar electrodes (stainless steel screw electrode) which were placed durally on the left sides of the frontal (motor area) and oc cipital cortex (visual area). According to the atlas of the rabbit brain by Sawyer et al. (18) , subcortical EEG's were recorded through the bipolar electrodes (stainless steel wire, diameter: 0.25 mm, insulated except for the tips) which were inserted into the left sides of the amygdala (A: 0.3, L: 6.0, H: 20) and hip pocampus (A: -4.7, L: 6.0, H: 8.0). An indif ferent electrode was placed on the frontal skull. Following the operative procedures, ether anesthesia was withdrawn, and the rabbit was immobilized with gallamine tri ethiodide (10 mg/kg, i.v. and an additional 10 mg/kg, s.c.) and artificially ventilated (SN 480-4, Shinano Seisakusho). The experiment was started from at least 2 hr after the ether anesthesia was discontinued.
In the spon taneous EEG experiment, the test drugs were orally administered, but in the experiment for the antagonistic effect on anesthetized EEG, they were intravenously injected 10 min after i.v. administration of 10 mg/kg of pentobarbi tal. In order to remove the influence of pain on the EEG, all the wound edges and pressure points were locally anesthetized with 2% lidocaine hydrochloride jelly (Xylocaine®, Fujisawa). and significantly shortened the duration of pentobarbital-induced sleep at 0.3 mg/kg or more and at 100 mg/kg or more, respectively ( Table 1 ). The activities after oral administrations of TA-0910 and TRH were about 1 /10 and 1 /100 those after i.v. administration, respectively, when com pared on the basis of their doses. The shorten ing effects of TA-0910 and TRH on the dura tion of pentobarbital-induced sleep were reduced in inverse proportion to the time in terval between the drug administration and pentobarbital treatment ( Table 2 ). Effect on locomotor activity: TA-0910 had almost no effect on locomotor activity at 3 and 10 mg/kg given orally. At 30 mg/kg, however, the activity during each 30 min period at 30, 60, 90, 120 and 150 min and total activity for 180 min after administration significantly in creased. TRH had no effect on the locomotor activity at 100 and 300 mg/kg given orally. At 1000 mg/kg, TRH significantly increased the activity only at 30 and 120 min after adminis tration, but not the total activity for 180 min (Fig. 2) .
Effect on reserpine-induced hypothermia: TA-091 0 and TRH dose-dependently reversed the reserpine-induced hypothermia in mice when administered orally as well as intraperi toneally (Fig. 3) . The reversal effect of TA 0910 administered orally reached a peak 2-3 hr after administration and gradually de creased. However, no complete recovery to the control level was observed at 1 and 3 mg/ kg orally or at 0.1 and 0.3 mg/kg intraperi toneally even at 5 and 3 hr after administra tion, respectively.
On the other hand, the effect of TRH reached a peak 1 hr and 0.5 hr after the oral and intraperitoneal administra tions, respectively; and no significant dif ference was observed between the TRH treated groups and the control group at 5 hr after oral administration or at 3 hr after i.p. administration. The p.o./i.p. dose ratios of TA 0910 and TRH were about 1/10 and 1/30, respectively, when compared with the mini mum dose producing significant reversal effects (Fla. 3). Effect on EEG: TA-0910 had almost no effect on spontaneous EEG's in the 2 rabbits at 0.1 mg/kg orally, but at 1 mg/kg, it induced low voltage (50-100 ,aV) fast waves in corti cal and amygdaloid EEG's and increased hip pocampal B rhythms in all 3 rabbits from about 10-30 min after administration. These changes lasted for more than 180 min (Table  3 , Fig. 4) . The same changes were observed in 1 of 3 animals given 100 mg/kg of TRH orally from 60 to 120 min after administration (Table 3) .
TA-0910 had no effect on the EEG drowsy pattern induced by the intravenous injection of 10 mg/kg of pentobarbital at 0.1 mg/kg intravenously (n=2), but at 0.3 mg/kg, it changed the drowsy pattern into the arousal pattern lasting for about 20 min in all 3 rabbits from a few after administration (Table 4 , Fig.  5 ). A similar effect was observed after i.v. ad ministration of 3 mg/kg of TRH (n=3) ( Table  4) . 
Discussion
TA-0910, a new TRH analog, at lower doses (0.3-1 mg/kg, p.o.) showed such ef fects as shortening of the duration of pen tobarbital-induced sleep, antagonism to re serpine-induced hypothermia and activation of EEG, and at a higher dose (30 mg/kg, p.o.), it also enhanced locomotor activity. There were no qualitative differences between the CNS effects of TA-0910 and TRH.
The oral dose of TA-0910 required for shortening the duration of pentobarbital induced sleep was about 1 /100 that required for an increase in locomotor activity. In rodents, antagonism to pentobarbital-induced sleep and enhancement of motor activity are known to have a close relation with acetyl cholinergic (ACh) (19, 20) and dopaminergic (DA) neurons (21, 22), respectively. TA-091 0 has an antagonistic effect on reduction of ACh turn-over rate in pentobarbital-treated rat brain (K. Kawashima et al., personal com munication).
Increase in locomotor activity caused by TA-0910 was antagonized by pre treatment with the DA antagonist haloperidol and a-methyl-p-tyrosine in rats (M. Yama mura et al., unpublished data). Therefore, TA 0910 is considered to act more selectively on ACh neurons than on DA neurons. According ly, effects on the CNS after oral or i.v. ad ministration of lower doses of TA-0910, such as activation of spontaneous EEG and arousal action on EEG sleeping pattern induced by pentobarbital, appear to be due to its ac tivating action on ACh neurons.
When administered orally to mice, the ef fects of TA-091 0 on the CNS were about 30 300 times stronger and 8 times longer than those of TRH, and qualitatively different.
Brewster et al. (23) suggested that since the p.o./i.v. dose-ratio of the antagonistic ac tion of the TRH analog RX77368 against reserpine-induced hypothermia was markedly smaller than that of TRH, the potency after oral administration is dependent on the ab sorption rates of these drugs from the gas trointestinal tract. Considering this sugges tion, the gastrointestinal absorption rate of TA-0910 is higher than that of TRH because the p.o./i.v. dose-ratios of the antagonistic effects of TA-0910 against pentobarbital induced sleep and reserpine-induced hypo thermia, respectively, were 1/10-1/3 those of TRH.
Pharmacokinetic studies in rats revealed that orally administered
[14C]-TA-0910 was absorbed throughout the small intestinal tract without being broken down by digestive enzymes in the stomach and the small in testine, and that [14C]-TA-0910
was not degraded by TRH catabolic enzymes, es pecially thyroliberinase, which has a high substrate specificity, in rat plasma in vitro (S. Furuuchi et al., personal communication) .
On the other hand, orally administered
[3H] TRH was absorbed only in the upper part of the small intestine (13). In rat plasma in vitro, the labeled TRH underwent enzymatic de gradation with a half-life of about 5 min (24). Therefore, the higher potency and the longer duration of action of TA-0910 can be better explained by considering the absorption from the gastrointestinal tract and the stability toward TRH catabolic enzymes. Although TRH analogs MK-774, RX77368, and DN 1417 had more potent CNS actions than TRH, the affinities of these drugs for TRH re ceptors were only about 1/10, 1/100, and 1/150 that of TRH, respectively (25). These results suggest that there is no correlation between the affinity for TRH receptors and CNS actions.
Simasko and Horita (26) demonstrated that the potent CNS actions of TRH analogs MK-771 and DN-1417 are probably attributed to their high resistance to TRH catabolic enzymes, but not to the degree of TRH receptor affinity. Friderichs et al. (27) also pointed out that the potent and prolonged CNS actions of the TRH analog CG-3509 were related to its high stability in the plasma.
Thus, the quantitative difference between TA-0910 and TRH after oral administration in their CNS actions is considered to be related to absorption in the small intestine and to resistance to TRH catabolic enzymes, es pecially thyroliberinase.
